arrow
Back
J

John P. Leonard

new york university

85H-index
818Paper Count
3.1WCitation Count
Published Papers 135
Publication Date
Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826)
err2026-07-31
err0
errOAAI
errSairah Ahmed; Hongli Li; Alex F. Herrera; Anamarija M. Perry; Alexandra E. Kovach; Sarah C. Rutherford; Kelly Davison; Sharon M. Castellino; Andrew M. Evens; Brad Kahl; Nancy L. Bartlett; John P. Leonard; Margaret A. Shipp; Sonali M. Smith; Kara M. Kelly; Michael LeBlanc; Jonathan W. Friedberg; Joo Y. Song
errShare
errSave
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop
err2025-12-05
err0
errOAAI
errReid Merryman; Sarah C. Rutherford; Stephen Ansell; Philippe Armand; John P. Leonard; Loretta Nastoupil; Sonali M. Smith; John Timmerman; Andrew D. Zelenetz; Meghan Gutierrez; Wendy Béguelin; Carla Casulo; James Cerhan; Michael Green; Brad Kahl; Robert Kridel; Brian Link; Matthew J. Maurer; Bertrand Nadel; Andrea J. Radtke
errShare
errSave
Comparative Infection Risk in CAR T vs Bispecific Antibodies in B cell Lymphoma: A Systematic Review and Meta-Analysis
err2025-07-03
err0
errOAAI
errHerman van Besien; Neela Easwar; Michelle Demetres; Michelle Pasciolla; Tsiporah Shore; John Leonard; Juliet Barker; Peter Martin; Samuel Yamshon
errShare
errSave
Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022
err2025-03-05
err0
errOAAI
errAjay K. Gopal; Philippe Armand; Sattva S. Neelapu; Nancy L. Bartlett; Stephen E. Spurgeon; John Kuruvilla; Kerry J. Savage; John P. Leonard; Arnold B. Gelb; Nasir Ahmed; Shiqi Dong; Sai Praneeth Bathena; Rasika Suryawanshi; Jenny Qun Wu; Sheen Wang; Douglas E. Gladstone
errShare
errSave
The future of follicular lymphoma management: strategies on the horizon
errBlood
IF23.1
err2025-03-04
err0
PREAI
errErin Mulvey; Sarah C. Rutherford; John P. Leonard
errShare
errSave
Vitamin D in patients with low tumor-burden indolent non- Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial
err2024-12-01
err1
errOAAI
errFriedberg, Jonathan W.; Brady, Michael T.; Strawderman, Myla; Kahl, Brad S.; Lossos, Izidore S.; Cohen, Jonathon B.; Reagan, Patrick M.; Casulo, Carla; Averill, Barbara L.; Baran, Andrea; Sutamtewagul, Grerk; Barr, Paul M.; Leonard, John P.; Ashton, John M.; Strang, John G.; Vega, Francisco; Peterson, Derick R.; Nastoupil, Loretta J.
errShare
errSave
Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized Trial
errBLOOD
IF23.1
err2024-11-25
err2
PREAI
errFenske, Timothy S.; Wang, Xin Victoria; Till, Brian G.; Blum, Kristie A.; Lunning, Matthew; Lazarus, Hillard M.; Fishkin, Paul A. S.; Shields, Lale Kostakoglu; Scott, David W.; Lacasce, Ann S.; Johnston, Patrick B.; Cashen, Amanda F.; Popplewell, Leslie L.; Dean, Robert M.; Ahmed, Nausheen; Shah, Nirav N.; Wagner-Johnston, Nina D.; Hu, Boyu; Dholaria, Bhagirathbhai R.; Little, Richard F.; Friedberg, Jonathan W.; Leonard, John P.; Kahl, Brad S.
errShare
errSave
MRD-Driven Time-Limited Therapy of Acalabrutinib and Lenalidomide Plus Rituximab (ALR) or Obinutuzumab (ALO) in Patients with Treatment-Naive Mantle Cell Lymphoma: Phase 2 Trial Outcomes with MRD and cfDNA Analyses
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errRuan, Jia; Bond, David A.; Shah, Bijal; Allan, John N.; Rutherford, Sarah C.; Gribbin, Caitlin; Chen, Zhengming; Hobbie, Brittany; Harbhajan, Melinda; Sahni, Tejasvi; Tam, Wayne; Bhinder, Bhavneet; Sigouros, Michael; Inghirami, Giorgio; Chen-Kiang, Selina; Elemento, Olivier; Maddocks, Kami J.; Leonard, John P.; Martin, Peter
errShare
errSave
Addition or Substitution of Acalabrutinib in Intensive Frontline Chemoimmunotherapy for Patients ≤ 70 Years Old with Mantle Cell Lymphoma: Outcomes of the 3-Arm Randomized Phase II Intergroup Trial ECOG-ACRIN EA4181
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errWagner-Johnston, Nina; Jegede, Opeyemi; Spurgeon, Stephen E.; Maddocks, Kami J.; Yang, David T.; Romanoff, Justin; Paludo, Jonas; Caimi, Paolo F.; Bartlett, Nancy L.; Reagan, Patrick M.; Sawalha, Yazeed; Hoffmann, Marc; Hu, Boyu; Aziz, Ashraf R.; Marques, Helga; Shields, Lale Kosakoglu; Leonard, John P.; Friedberg, Jonathan W.; Kahl, Brad S.
errShare
errSave
Disrupting IL10 Signaling Overcomes Compound Copy Number Variation-Driven Clinical Resistance to CDK4/6 and BTK Inhibition in Mantle Cell Lymphoma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errDi Liberto, Maurizio; Hu, Yang; Huang, Xiangao; Inghirami, Giorgio; Wang, Kevin; Lee, Christina Y.; Maddocks, Kami J.; Blum, Kristie A.; Ruan, Jia; Leonard, John P.; Bartlett, Nancy L.; Martin, Peter; Elemento, Olivier; Chen-Kiang, Selina
errShare
errSave
Representation of Minorities in Therapeutic Clinical Trials- a 15-Year Review of Lymphoma Cooperative Group Studies (Alliance A152123)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errAlencar, Alvaro J.; Geyer, Susan M.; Paskett, Electra; Pederson, Levi D.; Dockter, Travis; Ghosh, Nilanjan; Adekola, Kehinde; Unger, Joseph M.; Jegede, Opeyemi; Friedberg, Jonathan W.; Kahl, Brad S.; Dinner, Shira N.; Bartlett, Nancy L.; Blum, Kristie A.; Leonard, John P.
errShare
errSave
Nivolumab plus AVD in Advanced-Stage Classic Hodgkin's Lymphoma
err2024-10-17
err2
PREAI
errHerrera, A. F.; LeBlanc, M.; Castellino, S. M.; Li, H.; Rutherford, S. C.; Evens, A. M.; Davison, K.; Punnett, A.; Parsons, S. K.; Ahmed, S.; Casulo, C.; Bartlett, N. L.; Tuscano, J. M.; Mei, M. G.; Hess, B. T.; Jacobs, R.; Saeed, H.; Torka, P.; Hu, B.; Moskowitz, C.; Kaur, S.; Goyal, G.; Forlenza, C.; Doan, A.; Lamble, A.; Kumar, P.; Chowdhury, S.; Brinker, B.; Sharma, N.; Singh, A.; Blum, K. A.; Perry, A. M.; Kovach, A.; Hodgson, D.; Constine, L. S.; Shields, L. K.; Prica, A.; Dillon, H.; Little, R. F.; Shipp, M. A.; Crump, M.; Kahl, B.; Leonard, J. P.; Smith, S. M.; Song, J. Y.; Kelly, K. M.; Friedberg, J. W.
errShare
errSave
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101
err2024-06-14
err2
errOAAI
errBatchelor, Tracy T.; Giri, Sharmila; Ruppert, Amy S.; Geyer, Susan M.; Smith, Scott E.; Mohile, Nimish; Swinnen, Lode J.; Friedberg, Jonathan W.; Kahl, Brad S.; Bartlett, Nancy L.; Hsi, Eric D.; Cheson, Bruce D.; Wagner-Johnston, Nina; Nayak, Lakshmi; Leonard, John P.; Rubenstein, James L.
errShare
errSave
Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma
err2024-03-15
err2
errOAAI
errRutherford, Sarah C.; Yin, Jun; Pederson, Levi D.; Blum, Kristie A.; Martin, Peter; Jung, Sin -Ho; Grant, Barbara; Rosenbaum, Cara; Cheson, Bruce D.; Bartlett, Nancy L.; Mandrekar, Sumithra J.; Leonard, John P.
errShare
errSave
Implementation of a commercial federated network of electronic health record data to enable sponsor-initiated clinical trials at an academic medical center
err2024-02-01
err3
PREAI
errCampion Jr, Thomas R.; Sholle, Evan T.; Abedian, Sajjad; Fuld, Xiaobo; McGregor, Ryan; Lewis, Alicia N.; Gripp, Lauren T.; Leonard, John P.; Cole, Curtis L.
errShare
errSave
CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema
err2024-02-01
err45
PREAI
errLonghurst, Hilary J.; Lindsay, Karen; Petersen, Remy S.; Fijen, Laure M.; Gurugama, Padmalal; Maag, David; Butler, James S.; Shah, Mrinal Y.; Golden, Adele; Xu, Yuanxin; Boiselle, Carri; Vogel, Joseph D.; Abdelhady, Ahmed M.; Maitland, Michael L.; McKee, Mark D.; Seitzer, Jessica; Han, Bo W.; Soukamneuth, Samantha; Leonard, John; Sepp-Lorenzino, Laura; Clark, Eliana D.; Lebwohl, David; Cohn, Danny M.
errShare
errSave
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes
err2024-01-13
err6
PREAI
errCerhan, James R.; Maurer, Matthew J.; Link, Brian K.; Feldman, Andrew L.; Habermann, Thomas M.; Jaye, David L.; Burack, W. Richard; Mcdonnell, Timothy J.; Vega, Francisco; Chapman, Jennifer R.; Syrbu, Sergei; Vij, Kiran R.; Inghirami, Giorgio; Leonard, John P.; Bernal-Mizrachi, Leon; Farooq, Umar; Witzig, Thomas E.; Weiner, George J.; Wang, Yucai; Alderuccio, Juan P.; Slager, Susan L.; Larson, Melissa C.; Riska, Shaun M.; Gysbers, Brianna J.; Lunde, Julianne J.; Reicks, Tanner W.; Ayers, Amy A.; O'Leary, Colin B.; Yost, Kathleen J.; Liu, Hongfang; Nowakowski, Grzegorz S.; Ruan, Jia; Chihara, Dai; Koff, Jean L.; Casulo, Carla; Thompson, Carrie A.; Cohen, Jonathon B.; Kahl, Brad S.; Nastoupil, Loretta J.; Lossos, Izidore S.; Friedberg, Jonathan W.; Martin, Peter; Flowers, Christopher R.
errShare
errSave
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017
errCANCER
IF5.1
err2023-11-02
err1
errOAAI
errRosenberg, Shoshana M.; McCue, Shaylene; He, Jun; Lafky, Jacqueline M.; Carey, Lisa A.; Galanis, Evanthia; Leonard, John P.; Meyerhardt, Jeffrey; Ng, Kimmie; Schwartz, Gary K.; Stock, Wendy; Paskett, Electra D.; Partridge, Ann H.; George, Suzanne
errShare
errSave